Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • What is the optimal strategy for colon cancer surveillance in patients with ulcerative colitis?
    You have access
    What is the optimal strategy for colon cancer surveillance in patients with ulcerative colitis?
    William M. Bauer, MD and Bret A. Lashner, MD, MPH
    Cleveland Clinic Journal of Medicine May 1999, 66 (5) 273-277;
  • You have access
    COX 2-selective NSAIDs: Biology, promises, and concerns
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine May 1999, 66 (5) 285-292;

    A new family of nonsteroidal anti-inflammatory drugs promises to be substantially safer than current agents, but should not be assumed to be totally without adverse effects.

  • You have access
    Dear Colleague
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine May 1999, 66 (5) 199;
  • You have access
    New insulin replacement technologies: Overcoming barriers to tight glycemic control
    Camilo A. Leslie, MD
    Cleveland Clinic Journal of Medicine May 1999, 66 (5) 293-302;
  • You have access
    Colorectal cancer screening: Making sense of the different guidelines
    Carol Ann Burke, MD and Rosalind Van Stolk, MD
    Cleveland Clinic Journal of Medicine May 1999, 66 (5) 303-311;

    Colon cancer screening is dismally underused. A review of the guidelines from three different groups, with recommendations in areas of controversy.

  • You have access
    Resuscitating the exercise stress test
    Michael S. Lauer, MD
    Cleveland Clinic Journal of Medicine May 1999, 66 (5) 278-282;
  • You have access
    Gastrointestinal and renal involvement in vasculitis: Management strategies in Henoch-Schönlein purpura
    Ilona S. Szer, MD
    Cleveland Clinic Journal of Medicine May 1999, 66 (5) 312-317;
  • You have access
    Management of perimenopause: Focus on alternative therapies
    Holly L. Thacker, MD and Delbert L. Booher, MD
    Cleveland Clinic Journal of Medicine April 1999, 66 (4) 213-218;
  • You have access
    Diagnosis and treatment of glucocorticoid-induced osteoporosis
    Dina Zaqqa, MD and Rebecca D. Jackson, MD
    Cleveland Clinic Journal of Medicine April 1999, 66 (4) 221-230;

    Nearly everyone loses bone mass when they take corticosteroids long-term. Physicians should take proactive steps to mitigate the problem.

  • You have access
    United Kingdom Prospective Diabetes Study (UKPDS)
    Christian E. Nasr, MD, Byron J. Hoogwerf, MD, Charles Faiman, MD and S. Sethu K. Reddy, MD
    Cleveland Clinic Journal of Medicine April 1999, 66 (4) 247-253;

    A 20-year study shows that intensive hlood glucose control is beneficial in type 2 diabetes.

Pages

  • Previous
  • Next
  • 1
  • …
  • 429
  • 430
  • 431
  • 432
  • 433
  • 434
  • 435
  • 436
  • 437
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire